ETON

Eton Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website etonpharma.com
Employees(FY) 28
ISIN US29772L1089

Performance

+3.37%

+19.71%

+113.05%

+285.58%

+186.99%

YTD

+176.87%

Profile

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Advanced Technical Analysis

Technical Analysis of ETON 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 71 further supports this positive outlook. However, the Oscillators Score of 46 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ETON

Stock Rank

Recent News & Updates

2024-12-19 17:50
Eton Pharmaceuticals Closes Acquisition of Increlex (mecasermin injection)(Globenewswire)
2024-12-16 17:50
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial(Yahoo Finance)
2024-12-02 17:50
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer(Globenewswire)
2024-11-25 20:48
Eton acquires US rights to neonatal diabetes treatment from AMMTeK(Yahoo Finance)
2024-11-25 17:55
Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK(Yahoo Finance)
2024-11-24 17:50
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)(Globenewswire)
2024-11-12 18:09
Q3 2024 Eton Pharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-11-12 13:18
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...(Yahoo Finance)
2024-11-12 03:01
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results(Globenewswire)
2024-11-10 18:18
What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings(Yahoo Finance)
2024-11-06 18:00
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)(Globenewswire)
2024-11-06 03:30
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024(Globenewswire)
2024-10-28 21:30
Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum(Yahoo Finance)
2024-10-27 23:01
Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.(Yahoo Finance)
2024-10-17 04:15
SWK Holdings Provides Portfolio Update(Accesswire)
2024-10-08 13:02
Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares(Yahoo Finance)
2024-10-02 18:30
Eton Pharmaceuticals, Inc to Acquire Increlex (mecasermin injection) from Ipsen(Globenewswire)
2024-09-12 14:22
Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.(Yahoo Finance)
2024-08-22 04:30
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-08 09:59
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024(Investorplace)
2024-08-08 04:01
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-07-30 05:30
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024(Globenewswire)
2024-07-17 04:15
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update(Accesswire)
2024-07-15 04:05
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)(Globenewswire)
2024-05-09 22:11
Q1 2024 Eton Pharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-05-09 04:01
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results(Globenewswire)
2024-05-01 04:05
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference(Globenewswire)
2024-04-29 23:21
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400(Yahoo Finance)
2024-04-29 19:00
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)(Globenewswire)
2024-04-29 04:30
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.